Shijiazhuang Yiling Pharmaceutical Hits Day Low Amid Price Pressure at CNY 15.02

Shijiazhuang Yiling Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 5.15% on June 16, 2026. The stock reached an intraday low of CNY 15.02, reflecting a challenging trading session for the company. In terms of performance metrics, Shijiazhuang Yiling has faced a downward trend over various time frames. Over the past week, the stock has decreased by 0.98%, while the month-to-date performance shows a decline of 8.59%. Year-to-date, the stock is down 11.48%, significantly lagging behind the China Shanghai Composite, which has gained 3.1% during the same period. Despite these short-term challenges, the company has reported a robust net profit growth of 42.92% as of March 26, and has shown positive results for the last three consecutive quarters. Additionally, the operating cash flow reached a high of CNY 2,055.74 million, and raw material costs have decreased by 16.65% year-over-year. With a market capitalization of CNY 20,777 million, Shijiazhuang Yiling remains a significant player in the pharmaceuticals and biotechnology sector.